The anthracycline-like polyketide drug elloramycin is produced by Streptomyces olivaceus TĂŒ 2353. Elloramycin has antibacterial activity against Gram-positive bacteria and also exhibits antitumor activity. From a cosmid clone (cos16F4) containing part of the elloramycin biosynthesis gene cluster, three genes (elmMI, elmMII, and elmMIII) have been cloned. Sequence analysis and data base comparison showed that their deduced products resembled S-adenosylmethionine-dependent O-methyltransferases. The genes were individually expressed in Streptomyces albus and also coexpressed with genes involved in the biosynthesis of L-rhamnose, the 6-deoxysugar attached to the elloramycin aglycon. The resulting recombinant strains were used to biotransform three different elloramycin-type compounds: Lrhamnosyl-tetracenomycin C, L-olivosyl-tetracenomycin C, and L-oleandrosyl-tetracenomycin, which differ in their 2-, 3-, and 4-substituents of the sugar moieties. When only the three methyltransferase-encoding genes elmMI, elmMII, and elmMIII were individually expressed in S. albus, the methylating activity of the three methyltransferases was also assayed in vitro using various externally added glycosylated substrates. From the combined results of all of these experiments, it is proposed that methyltransferases ElmMI, ElmMII, and Elm-MIII are involved in the biosynthesis of the permethylated L-rhamnose moiety of elloramycin. ElmMI, ElmMII, and ElmMIII are responsible for the consecutive methylation of the hydroxy groups at the 2-, 3-, and 4-position, respectively, after the sugar moiety has been attached to the aglycon.A number of important bioactive compounds are produced by actinomycetes. Particularly, the streptomycetes are responsible for the biosynthesis of most of the bioactive compounds clinically useful or with application in veterinary and animal husbandry. Many of them are glycosylated compounds and, in this case, the biological activity is usually correlated with the presence of the sugars, being in some cases essential for activity. Most of these sugars belong to the large family of 6-deoxyhexoses (6DOHs), 1 which form part of a great number of natural products, and at least 70 different 6DOHs have been identified in various metabolites (1-3). In recent years, a number of genes encoding deoxysugar biosynthetic enzymes from antibiotic-producing microorganisms have been characterized. The first and common step in most 6DOH biosynthesis is the activation of D-glucose 1-phosphate into TDP D-glucose in a reaction catalyzed by a glucose-1-phosphate:TTP thymidylyl transferase. Then a key dehydration step takes place, by the action of a TDP-D-glucose-4,6-dehydratase, generating TDP-D-4-keto-6-deoxyglucose, a key intermediate of the 6DOH biosynthesis. In this step, the 6-position of the sugar gets deoxygenated, and the typical 5-methyl group (ÏC-6) is generated that will remain in the structure of all 6DOHs. These two "initial" enzymes are quite well conserved in many pathways, thus facilitating the use of the corresponding genes a...